ORCHARD- Optimising Home Assessment of Rural Patients

Inclusion Criteria

• •● Solid organ transplant recipient
• •* On the COVID-19 shielding list
• •* People with specific cancers
• •* People with cancer who had chemotherapy within the last 2 years
• •* People with lung cancer that have had radical radiotherapy within the last two years
• •* People with cancer of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at end stage treatment
• •* People that have had immunotherapy or other continuing antibody treatments for cancer within the last two years
• •* People that had other targeted cancer treatment which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors within the last two years
• •* People who had bone marrow or stem cell transplants in the last 6 months, or who are still taking immunosuppression drugs
• •* People with severe respiratory conditions including all cystic fibrosis, severe asthma, and severe COPD
• •* People with rare diseases and inborn errors of metabolism that significantly increase the risk of infections (such as SCID, homozygous sickle cell anaemia)
• •* People in immunosuppression therapies sufficient to significantly increase risk of infection
• •A GP working at the pilot study practice and carried out telemedicine consultations with participants
• •A GP who can provide informed consent